Analysis of a heterogeneous group of human breast carcinoma associated glycoproteins bearing the Tn determinant Eduardo OsinagaGianfranco PancinoAlberto Roseto Report Pages: 139 - 152
Expression of insulin-like growth factor binding proteins by T-47D human breast cancer cells: regulation by progestins and antiestrogens Amanda CouttsLiam J. MurphyLeigh C. Murphy Report Pages: 153 - 164
Thymidine labeling index and Ki-67 growth fraction in breast cancer: Comparison and correlation with prognosis M. RudasM. F. X. GnantA. Reiner Report Pages: 165 - 175
Constitutive overexpression of the 27,000 dalton heat shock protein in late passage human breast cancer cells Suzanne A. W. FuquaMargaret G. BenedixSteffi Oesterreich Report Pages: 177 - 186
Establishment and characteristics of two new human mammary carcinoma lines in nude mice with special reference to the estradiol receptor status and the importance of stroma forin vivo andin vitro growth Helga NaundorfIduna FichtnerSusanne Reinecke Report Pages: 187 - 196
Ploidy and S-phase fractions (SPF) of primary breast cancers and their nodal metastases Pierre S. HupperetsBert SchutteGeert H. Blijham Report Pages: 197 - 202
The relationship of urinary and plasma androgens to steroid receptors and menopausal status in breast cancer patients and their influence on survial Barbara H. MasonIan M. HoldawayRonald G. Kay Report Pages: 203 - 212
High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: A preventive mechanism of malignant tumor cells against complement attack? Paul HofmanBae -Li HsiBernard Rossi Report Pages: 213 - 219
Fine-needle aspiration technique for the concurrent immunocytochemical evaluation of multiple biologic parameters in primary breast carcinoma Cecilia BozzettiRita NizzoliGiorgio Cocconi Report Pages: 221 - 228
Positive immunostaining for platelet derived growth factor (PDGF) is an adverse prognostic factor in patients with advanced breast cancer L. SeymourW. R. Bezwoda Brief comunication Pages: 229 - 233